DGX vs UNH

DGX exhibits stable fundamental health with a Piotroski F-Score of 6/9 and a sustainable dividend payout ratio of 36.02%. While the company shows consistent earnings growth (15.5% YoY) and a long track record of beating estimates, it is currently caught between a conservative Graham Number ($115.21) and a growth-based Intrinsic Value ($266.98). The bullish fundamental outlook is heavily offset by a 0/100 technical trend and bearish insider sentiment, with 10 sell transactions and zero buys in the last six months. Consequently, the stock appears fundamentally sound but lacks immediate price momentum.

UnitedHealth Group presents a conflicted profile with a stable but mediocre Piotroski F-Score of 4/9 and a significant disconnect between current price ($323.48) and defensive fair value (Graham Number: $175.91). While revenue growth remains robust at 12.3%, the company has suffered a catastrophic collapse in YoY earnings growth (-99.9%), suggesting severe short-term headwinds or one-time accounting shocks. Technical trends are currently bearish (0/100), though a recent one-month bounce and a favorable Forward P/E of 16.08 indicate analyst expectations of a recovery. The stock is currently trading at a significant premium to its intrinsic value, relying heavily on its market dominance and future earnings normalization.